Safty, efficacy, and mortality in a long‐term cohort of patients with rheumatoid arthritis taking methotrexate: Folloup after a mean of 13.3 years
Open Access
- 1 May 1997
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 40 (5) , 984-985
- https://doi.org/10.1002/art.1780400533
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Long‐Term Prospective Study of the Use of Methotrexate in the Treatment of Rheumatoid ArthritisArthritis & Rheumatism, 1992
- Long‐Term Prospective Study of Methotrexate in the Treatment of Rheumatoid ArthritisArthritis & Rheumatism, 1992
- Analysis of improvement in individual rheumatoid arthritis patients treated with disease‐modifying antirheumatic drugs, based on the findings in patients treated with placeboArthritis & Rheumatism, 1990
- Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trialsJournal of Clinical Epidemiology, 1988
- A long‐term prospective study of the use of methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1988
- Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1988
- The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritisArthritis & Rheumatism, 1986